224 related articles for article (PubMed ID: 25602158)
1. Fibroadipose hyperplasia versus Proteus syndrome: segmental overgrowth with a mosaic mutation in the PIK3CA gene.
Youssefian L; Vahidnezhad H; Baghdadi T; Ghaznavi A; Li Q; Tabrizi M; Uitto J
J Invest Dermatol; 2015 May; 135(5):1450-1453. PubMed ID: 25602158
[No Abstract] [Full Text] [Related]
2. Clinical delineation and natural history of the PIK3CA-related overgrowth spectrum.
Keppler-Noreuil KM; Sapp JC; Lindhurst MJ; Parker VE; Blumhorst C; Darling T; Tosi LL; Huson SM; Whitehouse RW; Jakkula E; Grant I; Balasubramanian M; Chandler KE; Fraser JL; Gucev Z; Crow YJ; Brennan LM; Clark R; Sellars EA; Pena LD; Krishnamurty V; Shuen A; Braverman N; Cunningham ML; Sutton VR; Tasic V; Graham JM; Geer J; Henderson A; Semple RK; Biesecker LG
Am J Med Genet A; 2014 Jul; 164A(7):1713-33. PubMed ID: 24782230
[TBL] [Abstract][Full Text] [Related]
3. Clinical and Genetic Aspects of the Segmental Overgrowth Spectrum Due to Somatic Mutations in PIK3CA.
Kang HC; Baek ST; Song S; Gleeson JG
J Pediatr; 2015 Nov; 167(5):957-62. PubMed ID: 26340871
[No Abstract] [Full Text] [Related]
4. Klippel-Trenaunay syndrome belongs to the PIK3CA-related overgrowth spectrum (PROS).
Vahidnezhad H; Youssefian L; Uitto J
Exp Dermatol; 2016 Jan; 25(1):17-9. PubMed ID: 26268729
[TBL] [Abstract][Full Text] [Related]
5. Molecular Diagnosis of Mosaic Overgrowth Syndromes Using a Custom-Designed Next-Generation Sequencing Panel.
Chang F; Liu L; Fang E; Zhang G; Chen T; Cao K; Li Y; Li MM
J Mol Diagn; 2017 Jul; 19(4):613-624. PubMed ID: 28502725
[TBL] [Abstract][Full Text] [Related]
6. Molecular diagnosis of somatic overgrowth conditions: A single-center experience.
Lalonde E; Ebrahimzadeh J; Rafferty K; Richards-Yutz J; Grant R; Toorens E; Marie Rosado J; Schindewolf E; Ganguly T; Kalish JM; Deardorff MA; Ganguly A
Mol Genet Genomic Med; 2019 Mar; 7(3):e536. PubMed ID: 30761771
[TBL] [Abstract][Full Text] [Related]
7. Phenotypic heterogeneity in PIK3CA-related overgrowth spectrum.
Vahidnezhad H; Youssefian L; Baghdadi T; Sotoudeh S; Tavassoli A; Zeinali S; Afsharaalam S; Uitto J
Br J Dermatol; 2016 Oct; 175(4):810-4. PubMed ID: 27037860
[No Abstract] [Full Text] [Related]
8. A case of congenital lipomatous overgrowth, vascular malformations, epidermal nevi, spinal/skeletal anomalies and/or scoliosis syndrome with lipoatrophy as an important clinical manifestation.
Schreiber A; Grenier PO; Auger I
Pediatr Dermatol; 2017 Nov; 34(6):735-736. PubMed ID: 28833506
[TBL] [Abstract][Full Text] [Related]
9. Segmental overgrowth syndrome due to an activating PIK3CA mutation identified in affected muscle tissue by exome sequencing.
Rasmussen M; Sunde L; Weigert KP; Bogaard PW; Lildballe DL
Am J Med Genet A; 2014 May; 164A(5):1318-21. PubMed ID: 24665065
[TBL] [Abstract][Full Text] [Related]
10. Cloves syndrome: a case report and perinatal diagnostic findings.
Puvabanditsin S; Memon N; Chekmareva M; Di Stefano V; Mehta R
Genet Couns; 2014; 25(3):265-70. PubMed ID: 25365848
[TBL] [Abstract][Full Text] [Related]
11. Phosphatidylinositol-4,5-bisphosphate 3-kinase catalytic subunit alpha (PIK3CA)-related overgrowth spectrum: A brief report.
Denorme P; Morren MA; Hollants S; Spaepen M; Suaer K; Zutterman N; Labarque V; Legius E; Brems H
Pediatr Dermatol; 2018 May; 35(3):e186-e188. PubMed ID: 29493003
[TBL] [Abstract][Full Text] [Related]
12. [CLOVES syndrome: a malformational syndrome closely resembling Proteus syndrome].
Guillet A; Aubert H; Tessier MH; David A; Perret C; Penhoat M; Stalder JF; Barbarot S
Ann Dermatol Venereol; 2014; 141(8-9):507-13. PubMed ID: 25209813
[TBL] [Abstract][Full Text] [Related]
13. What's New in Genetic Skin Diseases.
Hill CR; Theos A
Dermatol Clin; 2019 Apr; 37(2):229-239. PubMed ID: 30850045
[TBL] [Abstract][Full Text] [Related]
14. Overgrowth Syndromes Caused by Somatic Variants in the Phosphatidylinositol 3-Kinase/AKT/Mammalian Target of Rapamycin Pathway.
Akgumus G; Chang F; Li MM
J Mol Diagn; 2017 Jul; 19(4):487-497. PubMed ID: 28502730
[TBL] [Abstract][Full Text] [Related]
15. Molecular analysis of a uterine broad ligament leiomyoma in a patient with CLOVES syndrome.
Karpathiou G; Chauleur C; Picot T; Peoc'h M
Pathol Res Pract; 2020 Dec; 216(12):153285. PubMed ID: 33190013
[TBL] [Abstract][Full Text] [Related]
16. What is your diagnosis?
Panteliades M; Silva CM; Gontijo B
An Bras Dermatol; 2016; 91(3):378-80. PubMed ID: 27438212
[TBL] [Abstract][Full Text] [Related]
17. Prenatal diagnosis of CLOVES syndrome confirmed by detection of a mosaic PIK3CA mutation in cultured amniocytes.
Emrick LT; Murphy L; Shamshirsaz AA; Ruano R; Cassady CI; Liu L; Chang F; Sutton VR; Li M; Van den Veyver IB
Am J Med Genet A; 2014 Oct; 164A(10):2633-7. PubMed ID: 25044986
[TBL] [Abstract][Full Text] [Related]
18. Proteus Syndrome: Case Report with Anatomopathological Correlation.
Arredondo Montero J; Bronte Anaut M; López-Gutiérrez JC
Fetal Pediatr Pathol; 2022 Oct; 41(5):861-864. PubMed ID: 34668833
[No Abstract] [Full Text] [Related]
19. Recent advances in the study of somatic mosaicism and diseases other than cancer.
Erickson RP
Curr Opin Genet Dev; 2014 Jun; 26():73-8. PubMed ID: 25050467
[TBL] [Abstract][Full Text] [Related]
20. Somatic frameshift mutation in PIK3CA causes CLOVES syndrome by provoking PI3K/AKT/mTOR pathway.
Yan W; Zhang B; Wang H; Mo R; Jiang X; Qin W; Ma L; Lin Z
Hereditas; 2021 Jun; 158(1):18. PubMed ID: 34074347
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
